These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status. Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease. Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626 [TBL] [Abstract][Full Text] [Related]
6. Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer. Divi V; Chen MM; Nussenbaum B; Rhoads KF; Sirjani DB; Holsinger FC; Shah JL; Hara W J Clin Oncol; 2016 Nov; 34(32):3892-3897. PubMed ID: 27480149 [TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma. Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021 [TBL] [Abstract][Full Text] [Related]
8. Incidence of contralateral-bilateral nodes in the human papillomavirus era. Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027 [TBL] [Abstract][Full Text] [Related]
10. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315 [TBL] [Abstract][Full Text] [Related]
11. Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold. Bu DD; Ferrandino R; Robinson EM; Liu S; Miles BA; Teng MS; Yao M; Genden EM; Chai RL Laryngoscope; 2021 Jan; 131(1):E184-E189. PubMed ID: 32348558 [TBL] [Abstract][Full Text] [Related]
12. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone. Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases. Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979 [TBL] [Abstract][Full Text] [Related]
14. Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study. Kato MG; Ellis MA; Nguyen SA; Day TA Head Neck; 2018 Feb; 40(2):338-348. PubMed ID: 28963823 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma. Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338 [TBL] [Abstract][Full Text] [Related]
18. Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Spector ME; Gallagher KK; Bellile E; Chinn SB; Ibrahim M; Byrd S; Chanowski EJ; Walline HM; Moyer JS; Prince ME; Wolf GT; Bradford CR; McHugh JB; Cordell K; Carey T; Worden FP; Eisbruch A; Chepeha DB Head Neck; 2014 Sep; 36(9):1233-40. PubMed ID: 23913653 [TBL] [Abstract][Full Text] [Related]
19. Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy. Jackson RS; Sinha P; Zenga J; Kallogjeri D; Suko J; Martin E; Moore EJ; Haughey BH Ann Surg Oncol; 2017 Nov; 24(12):3494-3501. PubMed ID: 28808988 [TBL] [Abstract][Full Text] [Related]
20. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]